Bank of America’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bank of America’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-511,953	Closed	-$5.14M	–	8365
2023 Q4	$5.14M	Buy	511,953 +511,288	+76,885%	+$2.32M	﹤0.01%	3532
2023 Q3	$1.92K	Sell	665 -1,633	-71%	-$5.97K	﹤0.01%	7152
2023 Q2	$8.76K	Sell	2,298 -5,826	-72%	-$16.3K	﹤0.01%	6895
2023 Q1	$15.1K	Buy	8,124 +3,841	+90%	+$8.03K	﹤0.01%	6833
2022 Q4	$9.85K	Sell	4,283 -25,958	-86%	-$79.5K	﹤0.01%	6924
2022 Q3	$97K	Sell	30,241 -28,219	-48%	-$91.8K	﹤0.01%	6364
2022 Q2	$322K	Sell	58,460 -27,744	-32%	-$86.3K	﹤0.01%	5747
2022 Q1	$200K	Sell	86,204 -138	-0.2%	-$470	﹤0.01%	6461
2021 Q4	$522K	Buy	86,342 +62,250	+258%	+$599K	﹤0.01%	5823
2021 Q3	$334K	Buy	+24,092	New	+$284K	﹤0.01%	5940

Bank of America's GRCL Position: Q1 2024 in Review

Bank of America sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 511,953 shares — an estimated $5.14M sold.

Bank of America first reported a position in GRCL in Q3 2021 and held it in 10 quarters. The position peaked at $5.14M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Bank of America reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Bank of America sold 511,953 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $5.14M.
Bank of America first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2021 and held it in 10 quarters.
Bank of America's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $5.14M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.